Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)
Preambolo 1
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) ( 1 ) , and in particular Articles 31(3) and 36(4) and Article 37(4)(a) thereof,
Whereas:
HAS ADOPTED THIS REGULATION:
recital 1recital 1
(1) Regulation (EU) 2016/429 establishes a new legislation framework for the prevention and control of diseases, which are transmissible to animals or humans. In particular, Regulation (EU) 2016/429 lays down disease-specific rules for the diseases listed in accordance with Article 5(1) thereof (listed diseases), and Article 9 thereof provides how those rules are to be applied to different categories of listed diseases. Regulation (EU) 2016/429 also provides for the Member States to establish compulsory eradication programmes for the listed diseases referred to in Article 9(1)(b) thereof, and for optional eradication programmes for listed diseases referred to in Article 9(1)(c) thereof, and for the approval of such programmes by the Commission. In addition, it provides for the approval by the Commission of the disease-free status or non-vaccination status of Member States or zones or compartments thereof with regard to certain listed diseases referred to in Article 9(1)(a), (b) and (c) of Regulation (EU) 2016/429.
recital 2recital 2
(2) Commission Implementing Regulation (EU) 2018/1882 ( 2 ) defines listed diseases into Categories A to E diseases, and provides that the disease prevention and control rules for listed diseases referred to in Article 9(1) of Regulation (EU) 2016/429 are to apply to the categories of listed diseases for the listed species and groups of listed species referred to in the table set out in the Annex to that Regulation. This Regulation should lay down rules that concern Category A, Category B or Category C diseases.
recital 3recital 3
(3) Regulation (EU) 2016/429 regards the following as listed diseases: infection with Brucella abortus, B. melitensis and B. suis , infection with Mycobacterium tuberculosis complex (MTBC), infection with rabies virus (RABV), enzootic bovine leucosis (EBL), infection with bluetongue virus (serotypes 1-24) (infection with BTV), bovine viral diarrhoea (BVD), infectious bovine rinotracheitis/infectious pustular vulvovaginitis (IBR/IPV), infection with Aujeszky’s disease virus (ADV), infestation with Varroa spp., infection with Newcastle disease virus, infection with highly pathogenic avian influenza (HPAI), viral haemorrhagic septicaemia (VHS), infectious haematopoietic necrosis (IHN), infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV), infection with Marteilia refringens , infection with Bonamia exitiosa , infection with Bonamia ostreae , and infection with white spot syndrome virus (WSSV). All those listed diseases fall within the definitions of Category A, Category B or Category C diseases laid down in Implementing Regulation (EU) 2018/1882, and are duly listed in the table in the Annex to that Implementing Regulation.
recital 4recital 4
(4) Commission Delegated Regulation (EU) 2020/689 ( 3 ) supplements the rules on eradication programmes and disease-free status for certain listed diseases of terrestrial, aquatic and other animals, as provided for in Regulation (EU) 2016/429. In particular, Delegated Regulation (EU) 2020/689 establishes criteria for the granting of disease-free status for Member States or zones or compartments thereof, and the requirements for the approval of eradication programmes for Member States or zones or compartments thereof.
recital 5recital 5
(5) Article 85 of Regulation (EU) 2020/689 provides that the Member States or zones thereof with an approved eradication programme or an approved surveillance programme for category C diseases before the date of application of that Regulation are to be deemed to have an approved eradication programme in accordance with that Regulation for a period of six years from the date of application of that Regulation. Accordingly, this limitation should be indicated in the relevant Annexes to this Regulation.
recital 6recital 6
(6) Article 280 of Regulation (EU) 2016/429 provides the rules for the maintenance of the existing disease-free status or approved eradication and surveillance programmes of Member States or zones or compartments thereof for certain listed diseases that were approved by Commission acts adopted in accordance with Council Directives 64/432/EEC ( 4 ) , 91/68/EEC ( 5 ) , 92/65/EEC ( 6 ) , 2005/94/EC ( 7 ) , 2006/88/EC ( 8 ) or 2009/158/EC ( 9 ) . In addition, Articles 84 and 85 of Delegated Regulation (EU) 2020/689 supplement the rules laid down in Regulation (EU) 2016/429 in that respect by laying down transitional measures concerning existing disease-free statuses, and existing approved eradication and surveillance programmes, with regard to those listed diseases.
recital 7recital 7
(7) For the sake of simplification and transparency, this Regulation should replace the lists of existing disease-free Member States, zones and compartments and the existing approved eradication and surveillance programmes set out in the Commission acts adopted pursuant to the Directives referred to in Article 280 of Regulation (EU) 2016/429 and in certain Directives referred to in Articles 84 and 85 of Delegated Regulation (EU) 2020/689 with lists set out in the Annexes to this Regulation.
recital 8recital 8
(8) For certain listed diseases, Delegated Regulation (EU) 2020/689 lays down rules for the first time for the approval of the disease-free status for Member States or zones or compartments thereof and therefore the provisions of Article 280 of Regulation (EU) 2016/429 do not apply to such situations. This is the case for infection with rabies virus (RABV), infection with bluetongue virus (serotypes 1-24) (infection with BTV), bovine viral diarrhoea (BVD) or infection with Bonamia exitiosa. Several Member States have submitted to the Commission applications to have disease-free status granted for those listed diseases. Following the assessment by the Commission, those applications have been shown to comply with the criteria of Sections 1 and 2 of Chapter 4 of Part II of Delegated Regulation (EU) 2020/689 that lay down rules for the granting of disease-free status for Member States or zones and compartments thereof. Therefore, the disease-free status of those Member States or the relevant zones or compartments thereof, should be granted and they should be duly listed in the Annexes to this Regulation.
recital 9recital 9
(9) For certain listed diseases, Delegated Regulation (EU) 2020/689 lays down rules for the approval of eradication programmes for Member States or zones or compartments thereof that are not subject to the provisions of Article 280 of Regulation (EU) 2016/429. This is the case for infection with Brucella abortus, B. melitensis and B. suis , infection with Mycobacterium tuberculosis complex (MTBC), infection with rabies virus (RABV), enzootic bovine leucosis (EBL), infection with bluetongue virus (serotypes 1-24) (infection with BTV), bovine viral diarrhoea (BVD) or infection with Bonamia exitiosa . Several Member States have submitted to the Commission applications to have the eradication programmes approved for those listed diseases. Following the assessment by the Commission, those applications have been shown to comply with the criteria of Chapters 2 and 3 of Part II of Delegated Regulation (EU) 2020/689 that lay down criteria to be complied with for the approval of eradication programmes for Category B and Category C diseases of terrestrial and aquatic animals, respectively. Therefore, those eradication programmes should be approved and the Member States or zones and compartments thereof should be duly listed in the Annexes to this Regulation.
recital 10recital 10
(10) For certain listed diseases, applications from Member States to have disease-free status granted or to have eradication programmes approved have not yet been received by the Commission or their assessment has not yet been finalised. Once received or once the assessment is finalised the relevant Member States, zones or compartments may be listed in the Annexes to this Regulation.
recital 11recital 11
(11) In addition, for infection with Brucella abortus, B. melitensis and B. suis a Member States has recently submitted to the Commission an application to have disease-free status from infection with Brucella abortus, B. melitensis and B. suis granted for a zone. Following the assessment by the Commission, the application has been shown to comply with the criteria of Article 71 of Delegated Regulation (EU) 2020/689 that lay down rules for the recognition of disease-free status based on eradication programmes. Therefore, the disease-free status of the zone should be granted and it should be duly listed in the Annexes to this Regulation.
recital 12recital 12
(12) With respect to avian influenza, Commission Regulation (EC) No 616/2009 ( 10 ) , which was adopted pursuant to Directive 2005/94/EC, provides for the approval by the Member States of poultry compartments and other captive birds’ compartments. The list of approved compartments is publicly available and the Commission’s website includes links to the internet-based information pages of the Member States. Poultry compartments and other captive birds’ compartments approved with respect to avian influenza under Regulation (EC) No 616/2009 should have their disease-free status maintained in accordance with Regulation (EU) 2016/429 and should be duly listed in the Annexes to this Regulation.
recital 13recital 13
(13) Commission Decision 2003/467/EC ( 11 ) lists the Member States and regions thereof with tuberculosis-free status, brucellosis-free status and EBL-free status in accordance with Directive 64/432/EEC. Those Member States and regions thereof should be duly listed in the Annexes to this Regulation.
recital 14recital 14
(14) Commission Decision 93/52/EEC ( 12 ) sets out the list of Member States and regions thereof with official brucellosis-free ( B. melitensis ) status in accordance Directive 91/68/EEC. Those Member States and regions thereof should be duly listed in the Annexes to this Regulation.
recital 15recital 15
(15) Commission Implementing Decision 2013/503/EU ( 13 ) sets out the list of Member States or territories thereof which are recognised as free from varroosis in accordance with Directive 92/65/EEC. Those Members States or territories thereof should be duly listed in the Annexes to this Regulation.
recital 16recital 16
(16) Commission Decisions 94/963/EC ( 14 ) and 95/98/EC ( 15 ) establish the status of Finland and Sweden as ‘non-vaccinating’ as regards Newcastle disease in accordance with Directive 2009/158/EC. Those Member States should be duly listed in the Annexes to this Regulation.
recital 17recital 17
(17) Commission Decision 2004/558/EC ( 16 ) sets out the lists of regions of Member States that have the IBR-free status and the regions of Member States that have an approved IBR eradication programme in accordance with Directive 64/432/EEC. The regions with IBR-free status should be duly listed in the Annexes to this Regulation, whereas the regions with approved IBR eradication programmes should maintain their programme for a limited period of time in accordance with Regulation (EU) 2020/689, and should be listed in the Annexes to this Regulation.
recital 18recital 18
(18) Commission Decision 2008/185/EC ( 17 ) sets out the lists of Member States or regions thereof that have the Aujeszky’s disease-free status and the regions that have an approved Aujeszky’s disease eradication programme in accordance with Directive 64/432/EEC. Those Member States or regions thereof with Aujeszky’s disease-free status should be duly listed in the Annexes to this Regulation, whereas the regions with approved Aujeszky’s disease eradication programmes should maintain them for a limited period of time in accordance with Regulation (EU) 2020/689, and should be duly listed in the Annexes to this Regulation.
recital 19recital 19
(19) Commission Decision 2009/177/EC ( 18 ) establishes lists of Member States and certain zones and compartments with disease-free status, or subject to approved surveillance programmes or eradication programmes with regard to listed diseases of aquatic animals in accordance with Directive 2006/88/EC. The disease-free status of those Member States, zones and compartments should be duly listed in the Annexes to this Regulation, whereas the approved programmes should be maintained for a limited period of time in accordance with Article 85 of Regulation (EU) 2020/689, and should be duly listed in the Annexes to this Regulation.
recital 20recital 20
(20) With regard to listed diseases of aquatic animals, there are certain disease-free zones and compartments, and approved surveillance programmes, not listed in Decision 2009/177/EC but lists of which are publicly available on the internet-based information pages of the Member States in accordance with Directive 2006/88/EC. Those zones and compartments should have their disease-free status maintained, whereas the programmes should be maintained for a limited period in accordance with Article 85 of Regulation (EU) 2020/689. Up-to-date information concerning the establishments that are located in those disease-free zones and compartments, or which are subject to those programmes, are set out in the publicly available internet page that has been established and maintained in accordance with Article 185(3) of Regulation (EU) 2016/429 and with Article 21(2) of Commission Delegated Regulation (EU) 2020/691 ( 19 ) .
recital 21recital 21
(21) As the lists set out in Decisions 93/52/EEC, 94/963/EC, 95/98/EC, 2003/467/EC, 2004/558/EC, 2008/185/EC and 2009/177/EC, Regulation (EC) No 616/2009 and Implementing Decision 2013/503/EU are being replaced by the lists set out in the Annexes to this Regulation, those acts should be repealed and replaced by this Regulation.
recital 22recital 22
(22) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community (Withdrawal Agreement), and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, Regulation (EU) 2016/429, as well as the Commission acts based on it, apply to and in the United Kingdom in respect of Northern Ireland after the end of the transition period provided for in the Withdrawal Agreement. For that reason, the United Kingdom (Northern Ireland) should be listed in the Annexes to this Regulation where relevant for Northern Ireland.
recital 23recital 23
(23) As Regulation (EU) 2016/429 applies from 21 April 2021, this Regulation should also apply from that date.
recital 24recital 24
(24) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
Articolo 1Subject matter and scope
1.This Regulation lays down implementing rules for the listed diseases referred to in Article 9(1)(a), (b) and (c) of Regulation (EU) 2016/429 of animals, as regards the disease-free and non-vaccination status of certain Member States ( 1 ) or zones or compartments thereof, and the approval of eradication programmes for those listed diseases.
2.The Annexes to this Regulation list both the Member States or zones or compartments thereof whose disease-free status or eradication programmes shall be deemed to be approved as provided for in Article 280 of Regulation (EU) 2016/429, and those whose disease-free status and eradication programmes shall be duly approved by this Regulation and also duly listed in the Annexes thereto.
3.This Regulation lists in the Annexes thereto: (a) the Member States or zones or compartments thereof with approved compulsory eradication programmes for Category B diseases and optional eradication programmes for Category C diseases. (b) the Member States or zones thereof with approved disease-free status and non-vaccination status; (c) the compartments of Member States with recognised disease-free status.
Articolo 2Infection with Brucella abortus , B. melitensis and B. suis
1.The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part I of Annex I.
2.The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part I of Annex I.
3.The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part II of Annex I.
4.The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part II of Annex I.
Articolo 3Infection with Mycobacterium tuberculosis complex ( M. bovis, M. caprae and M. tuberculosis ) (MTBC)
1.The Member States or zones thereof with disease-free status from infection with Mycobacterium tuberculosis complex ( Mycobacterium bovis, M.caprae and M. tuberculosis ) (MTBC) shall be listed in Part I of Annex II.
2.The Member States or zones thereof with an approved compulsory eradication programme for infection with MTBC shall be listed in Part II of Annex II.
Articolo 4Infection with rabies virus (RABV)
1.The Member States or zones thereof with disease-free status from infection with rabies virus (RABV) shall be listed in Part I of Annex III.
2.The Member States or zones thereof with an approved compulsory eradication programme for infection with RABV shall be listed in Part II of Annex III.
Articolo 5Enzootic bovine leukosis (EBL)
1.The Member States or zones thereof with disease-free status from enzootic bovine leukosis (EBL) shall be listed in Part I of Annex IV.
2.The Member States or zones thereof with an approved optional eradication programme for EBL shall be listed in Part II of Annex IV.
Articolo 6Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)
1.The Member States or zones thereof with disease-free status from infectious bovine rinotracheitis/infectious pustular vulvovaginitis (IBR/IPV) shall be listed in Part I of Annex V.
2.The Member States or zones thereof with an approved optional eradication programme for IBR/IPV shall be listed in Part II of Annex V.
Articolo 7Infection with Aujeszky’s disease virus(ADV)
1.The Member States or zones thereof with disease-free status from infection with Aujeszky’s disease virus (ADV) shall be listed in Part I of Annex VI.
2.The Member States or zones thereof with an approved optional eradication programme for infection with ADV shall be listed in Part II of Annex VI.
Articolo 8Bovine viral diarrhoea (BVD)
1.The Member States or zones thereof with disease-free status from Bovine viral diarroea (BVD) shall be listed in Part I of Annex VII.
2.The Member States or zones thereof with an approved optional eradication programme for infection with BVD shall be listed in Part II of Annex VII.
Articolo 10Infestation with Varroa spp.
The Member States or zones thereof with disease-free status from infestation with Varroa spp. shall be listed in Annex IX.
Articolo 11Infection with Newcastle disease virus
The Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination shall be listed in Annex X.
Articolo 12Infection with highly pathogenic avian influenza (HPAI)
Compartments of the Member States free from HPAI shall be listed in Annex XI.
Articolo 13Viral haemorrhagic septicaemia (VHS)
1.The following shall be listed in Part I of Annex XII: (a) Member States where their whole territory has disease-free status from viral haemorrhagic septicaemia (VHS); (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and (c) zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.The following shall be listed in Part II of Annex XII: (a) Member States where their whole territory has an approved eradication programme for VHS; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS; and (c) zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Articolo 14Infectious haematopoietic necrosis (IHN)
1.The following shall be listed in Part I of Annex XIII: (a) Member States where their whole territory has disease-free status from infectious haematopoietic necrosis (IHN); (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN; and (c) zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.The following shall be listed in Part II of Annex XIII: (a) Member States where their whole territory has an approved eradication programme for IHN; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and (c) zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Articolo 15Infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV)
1.The following shall be listed in Part I of Annex XIV: (a) Member States where their whole territory has disease-free status from infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV); (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and (c) zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.The following shall be listed in Part II of Annex XIV: (a) Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and (c) zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Articolo 16Infection with Marteilia refringens
1.The following shall be listed in Part I of Annex XV: (a) Member States where their whole territory has disease-free status from infection with Marteilia refringens ; (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens ; and (c) zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.The following shall be listed in Part II of Annex XV: (a) Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens ; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens ; and (c) zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Articolo 17Infection with Bonamia exitiosa
1.The following shall be listed in Part I of Annex XVI: (a) Member States where their whole territory has disease-free status from infection with Bonamia exitiosa ; (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa ; and (c) zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.The following shall be listed in Part II of Annex XVI: (a) Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa ; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa ; and (c) zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Articolo 18Infection with Bonamia ostreae
1.The following shall be listed in Part I of Annex XVII: (a) Member States where their whole territory has disease-free status from infection with Bonamia ostreae ; (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae ; and (c) zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.The following shall be listed in Part II of Annex XVII: (a) Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae ; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae ; and (c) zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Articolo 19Infection with white spot syndrome virus (WSSV)
1.The following shall be listed in Part I of Annex XVIII: (a) Member States where their whole territory has disease-free status from infection with white spot syndrome virus (WSSV); (b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and (c) zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
2.The following shall be listed in Part II of Annex XVIII: (a) Member States where their whole territory has an approved eradication programme for infection with WSSV; (b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and (c) zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Articolo 19aInfestation with Echinococcus multilocularis
The Member States or zones thereof with disease-free status from infestation with Echinococcus multilocularis shall be listed in Annex XIX.
Articolo 20Repeal
The following acts are repealed:
— Decision 93/52/EEC,
— Decision 94/963/EC,
— Decision 95/98/EC,
— Decision 2003/467/EC,
— Decision 2004/558/EC,
— Decision 2008/185/EC,
— Decision 2009/177/EC,
— Regulation (EC) No 616/2009,
— Implementing Decision 2013/503/EU.
Articolo 21Entry into force and application
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .
It shall apply from 21 April 2021.
Allegato IANNEX I
INFECTION WITH BRUCELLA ABORTUS, B. MELITENSIS AND B. SUIS
PART I
Disease-free status from infection with Brucella abortus, B. melitensis and B. suis
CHAPTER 1
Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations
Member State ( *1 ) Territory Belgium Whole territory Czechia Whole territory Denmark Whole territory Germany Whole territory Estonia Whole territory Ireland Whole territory Spain Whole territory France Whole territory Croatia Whole territory Italy Regione Abruzzo: Provincia di Pescara, Teramo, Chieti Regione Basilicata: Provincia di Matera Regione Calabria: Provincia di Vibo Valentia Regione Campania: Provincia di Avellino, Benevento, Napoli Regione Emilia-Romagna Regione Friuli Venezia Giulia Regione Lazio Regione Liguria Regione Lombardia Regione Marche Regione Molise Regione Piemonte Regione Puglia: Provincia di Bari, Barletta-Andria-Trani, Brindisi, Lecce Regione Sicilia: Provincia de Agrigento, Trapani, Caltanissetta Regione Sardegna Regione Toscana Regione Trentino – Alto Adige Regione Umbria Regione Valle d’Aosta Regione Veneto Cyprus Whole territory Latvia Whole territory Lithuania Whole territory Luxembourg Whole territory Hungary Whole territory Malta Whole territory Netherlands Whole territory Austria Whole territory Poland Whole territory Portugal Distritos Aveiro, Castelo Branco, Coimbra, Faro, Guarda, Leiria, Santarem, Setubal, Viseu Região Autónoma dos Açores: Ilhas de Corvo, Faial, Flores, Graciosa, Pico, São Jorge, Santa Maria, Terceira Romania Whole territory Slovenia Whole territory Slovakia Whole territory Finland Whole territory Sweden Whole territory United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
CHAPTER 2
Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations
Member State ( *1 ) Territory Belgium Whole territory Czechia Whole territory Denmark Whole territory Germany Whole territory Estonia Whole territory Ireland Whole territory Spain Whole territory France Whole territory Croatia Whole territory Italy Regione Abruzzo Regione Basilicata: Province di Matera Regione Calabria: Province di Catanzaro, Cosenza Regione Campania: Provincia di Benevento, Napoli, Salerno Regione Emilia-Romagna Regione Friuli Venezia Giulia Regione Lazio Regione Liguria Regione Lombardia Regione Marche Regione Molise Regione Piemonte: Provincia de Asti, Biella, Cuneo, Novara, Verbano-Cusio-Ossola, Vercelli and Citta Metropolitana di Torino Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto Regione Sardegna Regione Toscana Regione Trentino – Alto Adige Regione Umbria Regione Valle d’Aosta Regione Veneto Cyprus Whole territory Latvia Whole territory Lithuania Whole territory Luxembourg Whole territory Hungary Whole territory Netherlands Whole territory Austria Whole territory Poland Whole territory Portugal Região Autónoma dos Açores Romania Whole territory Slovenia Whole territory Slovakia Whole territory Finland Whole territory Sweden Whole territory United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis
CHAPTER 1
Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in bovine animal populations
Member State Territory Bulgaria Whole territory Greece Whole territory Italy Regione Abruzzo: Provincia dell’Aquila, Regione Basilicata: Provincia di Potenza Regione Calabria: Provincia di Catanzaro, Cosenza, Crotone, Reggio Calabria Regione Campania: Provincia di Caserta, Salerno Regione Puglia: Provincia di Foggia, Taranto Regione Sicilia except the Provincia of Agrigento,Trapani, Caltanissetta Portugal Distritos Beja, Braga, Braganca, Evora, Lisboa, Portalegre, Porto, Viana do Castelo, Vila Real Região Autónoma da Madeira Região Autónoma dos Açores: Ilha de São Miguel
CHAPTER 2
Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations
Member State Territory Bulgaria Whole territor Greece Whole territory Italy Regione Basilicata: Provincia di Potenza Regione Calabria: Province di Crotone, Reggio Calabria, Vibo Valentia Regione Campania: Provincia d’Avellino, Caserta Regione Piemonte: Provincia di Alessandria Regione Puglia: Provincia di Foggia Regione Sicilia Portugal Região Madeira Distritos Aveiro, Beja, Braga, Braganca, Castelo Branco, Coimbra, Evora, Faro, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu
Allegato IIANNEX II
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS COMPLEX (M. BOVIS, M. CAPRAE AND M. TUBERCULOSIS) (MTBC)
PART I
Member States or zones thereof with disease-free status from infection with MTBC
Member State Territory Belgium Whole territory Czechia Whole territory Denmark Whole territory Germany Whole territory Estonia Whole territory Spain Comunidad Autónoma de Aragón: provincia de Huesca Comunidad Autónoma de Canarias Comunidad Autónoma de Castilla y León: provincias de Burgos, León, Valladolid Comunidad Autónoma de Cataluña Comunidad Autónoma de Galicia Comunidad Autónoma de Islas Baleares Comunidad Autónoma de Murcia Comunidad Autónoma del País Vasco Comunidad Autónoma del Principado de Asturias France Whole territory Croatia Whole territory Italy Regione Abruzzo Regione Basilicata: Provincia di Matera Regione Calabria: Provincia di Catanzaro Regione Campania: Provincia di Napoli Regione Emilia-Romagna Regione Friuli Venezia Giulia Regione Lazio: Province di Frosinone, Latina, Rieti, Viterbo Regione Liguria Regione Lombardia Regione Marche: Province di Ancona, Ascoli Piceno, Fermo, Pesaro-Urbino Regione Molise Regione Piemonte Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto Regione Sardegna Regione Toscana Regione Trentino – Alto Adige Regione Umbria Regione Valle d’Aosta Regione Veneto Latvia Whole territory Lithuania Whole territory Luxembourg Whole territory Hungary Whole territory Netherlands Whole territory Austria Whole territory Poland Whole territory Portugal Região Algarve: all distritos Região Autónoma dos Açores except Ilha de São Miguel Slovenia Whole territory Slovakia Whole territory Finland Whole territory Sweden Whole territory
PART II
Member States or zones thereof with an approved eradication programme for infection with MTBC
Member State ( *1 ) Territory Bulgaria Whole territory Cyprus Whole territory Greece Whole territory Ireland Whole territory Italy Regione Basilicata: Provincia di Potenza Regione Calabria: Province di Cosenza, Crotone, Reggio Calabria, Vibo Valentia Regione Campania: Province d’Avellino, Caserta, Benevento, Salerno Regione Lazio: Provincia di Roma Regione Marche: Provincia di Macerata Regione Puglia: Provincia di Foggia Regione Sicilia Malta Whole territory Portugal Região Autónoma dos Açores: Ilha de São Miguel Região Autónoma da Madeira Distritos Aveiro, Beja, Braga, Bragança, Castelo Branco, Coimbra, Evora, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu Romania Whole territory Spain Comunidad Autónoma de Andalucía Comunidad Autónoma de Aragón Comunidad Autónoma de Cantabria Comunidad Autónoma de Castilla-La Mancha Comunidad Autónoma de Castilla y León: Province of Ávila, Palencia, Salamanca, Segovia, Soria, Zamora Comunidad Autónoma de Extremadura Comunidad Autónoma de La Rioja Comunidad Autónoma de Madrid Comunidad Autónoma de Navarra Comunidad Autónoma de Valencia United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Allegato IIIANNEX III
INFECTION WITH THE RABIES VIRUS (RABV)
PART I
Member States or zones thereof with disease-free status from infection with RABV
Member State ( *1 ) Territory Belgium Whole territory Bulgaria Whole territory Czechia Whole territory Denmark Whole territory Germany Whole territory Estonia Whole territory Ireland Whole territory Greece Whole territory Spain Whole territory France Whole territory Croatia Whole territory Italy Whole territory Cyprus Whole territory Latvia Whole territory Lithuania Whole territory Luxembourg Whole territory Hungary Whole territory except Szabolcs-Szatmár-Bereg megye Malta Whole territory Netherlands Whole territory Austria Whole territory Poland Voivodship Dolnośląskie: all powiaty Voivodship Kujawsko-pomorskie: all powiaty Voivodship Lubelskie the following powiaty: łukowski, rycki, puławski, opolski, kraśnicki, janowski, lubelski, m. Lublin, lubartowski, radzyński, parczewski, bialski, m. Biała Podlaska Voivodship Lubuskie: all powiaty Voivodship Łódzkie: all powiaty Voivodship Małopolskie: all powiaty Voivodship Mazowieckie: all powiaty Voivodship Opolskie: all powiaty Voivodeship Podkarpackie the following powiaty: stalowowolski, tarnobrzeski, m. Tarnobrzeg, niżański, leżajski, łańcucki Voivodship Podlaskie: all powiaty Voivodship Pomorskie: all powiaty Voivodship Śląskie: all powiaty Voivodship Świętokrzyskie: all powiaty Voivodship Warmińsko-mazurskie: all powiaty Voivodship Wielkopolskie: all powiaty Voivodship Zachodniopomorskie: all powiaty Portugal Whole territory Slovenia Whole territory Slovakia Whole territory, except the following regions: Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský Michalovce, Sobrance, Trebišov in kraj Košický Finland Whole territory Sweden Whole territory United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States or zones thereof with an approved eradication programme for infection with RABV
Member State Territory Hungary Szabolcs-Szatmár-Bereg megye Poland Voivodship Lubelskie the following powiaty: włodawski, łęczyński, świdnicki, krasnostawski, zamojski, m. Zamość, biłgorajski, chełmski, m. Chełm, hrubieszowski, tomaszowski Voivodship Podkarpackie: the following powiaty: lubaczowski, przeworski, jarosławski, rzeszowski, m. Rzeszów, strzyżowski, krośnieński, m. Krosno, sanocki, leski, bieszczadzki, przemyski, m. Przemyśl, Brzozowski, ropczycko-sędziszowski, jasielski, dębicki, mielecki, kolbuszowski Romania Whole territory Slovakia Region Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský Region Michalovce, Sobrance, Trebišov in kraj Košický
Allegato IVANNEX IV
ENZOOTIC BOVINE LEUKOSIS (EBL)
PART I
Member States or zones thereof with disease-free status from EBL
Member State ( *1 ) Territory Belgium Whole territory Czechia Whole territory Denmark Whole territory Germany Whole territory Estonia Whole territory Ireland Whole territory Spain Whole territory France Région Auvergne et Rhône-Alpes Région Bourgogne-Franche-Comté Région Bretagne Région Centre-Val de Loire Région Corse Région Grande Est Région Hauts-de-France Région Ile-de-France Région Normandie Région Nouvelle-Aquitaine Région Occitanie Région Pays de la Loire Région Provence-Alpes-Côte d’Azur Région Guadeloupe Région Guyane Région Martinique Région Mayotte Croatia Whole territory Italy Whole territory Cyprus Whole territory Latvia Whole territory Lithuania Whole territory Luxembourg Whole territory Netherlands Whole territory Austria Whole territory Poland Whole territory Portugal Whole territory, except Região Autónoma da Madeira Slovenia Whole territory Slovakia Whole territory Finland Whole territory Sweden Whole territory United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States or zones thereof with an approved eradication programme for EBL
Member State Territory Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
Allegato VANNEX V
INFECTIOUS BOVINE RHINOTRACHEITIS/INFECTIOUS PUSTULAR VULVOVAGINITIS (IBR/IPV)
PART I
Member States or zones thereof with disease-free status from IBR/IPV
Member State Territory Czechia Whole territory Denmark Whole territory Germany Whole territory Italy Regione Valle d’Aosta Regione Trentino – Alto Adige: Provincia Autonoma di Bolzano – Alto Adige Austria Whole territory Finland Whole territory Sweden Whole territory
PART II
Member States or zones thereof with an approved eradication programme for IBR/IPV
Member State Territory Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689 Belgium Whole territory 21 April 2021 France Région Auvergne et Rhône-Alpes Région Bourgogne-Franche-Comté Région Bretagne Région Centre-Val de Loire Région Grande Est Région Hauts-de-France Région Ile-de-France Région Normandie Région Nouvelle-Aquitaine Région Occitanie Région Pays de la Loire Région Provence-Alpes-Côte d’Azur 21 April 2021 Italy Region Friuli Venezia Giulia Regione Trentino – Alto Adige: Provincia Autonoma di Trento 21 April 2021 Luxembourg Whole territory 21 April 2021 Slovakia Kraj Bratislava Kraj Košice Kraj Prešov Kraj Trnava Kraj Žilina 5 June 2023
Allegato VIANNEX VI
AUJESZKY’S DISEASE VIRUS (ADV)
PART I
Member States or zones thereof with disease-free status from infection with ADV
Member State ( *1 ) Territory Belgium Whole territory Czechia Whole territory Denmark Whole territory Germany Whole territory Estonia Whole territory Ireland Whole territory France The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Côtes-d’Armor, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Finistère, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Ille-et-Vilaine, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Morbihan, Moselle, Nièvre, Nord, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines Italy Regione Friuli Venezia Giulia Regione Trentino – Alto Adige Regione Veneto Cyprus Whole territory Luxembourg Whole territory Hungary Whole territory Netherlands Whole territory Austria Whole territory Poland Whole territory Portugal Região Autónoma dos Açores Slovenia Whole territory Slovakia Whole territory Finland Whole territory Sweden Whole territory United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States or zones thereof with an approved eradication programme for infection with ADV
Member State Territory Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689 Spain Whole territory 21 April 2021 Italy Regione Abruzzo Regione Apulia Regione Basilicata Regione Calabria Regione Campania Regione Emilia-Romagna Regione Lazio Regione Liguria Regione Lombardia Regione Marche Regione Molise Regione Piemonte Regione Sicilia Regione Toscana Regione Valle d’Aosta Regione Umbria 21 April 2021 Lithuania Whole territory 21 April 2021 Portugal Whole peninsular territory 21 April 2021
Allegato VIIANNEX VII
BOVINE VIRAL DIARRHOEA (BVD)
PART I
Member States or zones thereof with disease-free status from BVD
Member State Territory Austria Whole territory Denmark Whole territory Finland Whole territory Germany Bundesland Baden-Württemberg Bundesland Bayern Bundesland Brandenburg Bundesland Bremen Bundesland Hamburg Bundesland Hessen Bundesland Mecklenburg-Vorpommern Bundesland Niedersachsen, except Landkreis Cuxhaven Bundesland Nordrhein-Westfalen, except Kreis Höxter Bundesland Schleswig-Holstein Bundesland Rheinland-Pfalz Bundesland Saarland Bundesland Sachsen Bundesland Sachsen-Anhalt Bundesland Thüringen Sweden Whole territory
PART II
Member States or zones thereof with an approved eradication programme for BVD
Member State Territory Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689 Germany Bundesland Berlin Bundesland Niedersachsen: Landkreis Cuxhaven Bundesland Nordrhein-Westfalen: Kreis Höxter 21.2.2022 Ireland Whole territory 18 July 2022
Allegato IXANNEX IX
INFESTATION WITH VARROA SPP.
Member States or zones thereof with disease-free status from infestation with Varroa spp.
Member State Territory Portugal Island of Corvo Island of Graciosa Island of São Jorge Island of Santa Maria Island of São Miguel Island of Terceira Finland Åland Islands, except the municipality of Brändö
Allegato XANNEX X
INFECTION WITH NEWCASTLE DISEASE VIRUS
Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination
Member State Territory Finland Whole territory
Allegato XIANNEX XI
HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI)
Compartments free from HPAI
Member State Name France ISA Bretagne, consisting in the establishments EDE 22080055, EDE 22277180, EDE 22203429, EDE 22059174 and EDE 22295000; SASSO Sabres, consisting in the establishment EDE 40246082; SASSO Soulitré, consisting in the establishment EDE 72341105. The Netherlands Institut de selection animale B.V, with approval number 2338, consisting in the following companies: — Institut de Selection Animale B.V., St. Anthonisweg 65 B, 5831 AD Boxmeer — ISA Siebengewald, Horsterbeekweg 5, 5853 GD Siebengewald — ISA Landhorst, Boekelsebaan 16, 5445 NH Landhorst — Mts. Everts, Riegshoogtendijk 146, 7913 TC Hollandscheveld — Mts. Van der Zee, Bakkeveenseweg 1, 9343 TB Een-West — Scherpenkate, Oosterkampen 2, 7722 VZ Dalfsen — Mts. Steverink, Dinxperloseweg 26b, 7064 LA Silvolde — Melitz V.O.F. Zeewolde, Ooievaarsweg 5, 3897 LG, Zeewolde.
Allegato XIIANNEX XII
VIRAL HAEMORRHAGIC SEPTICAEMIA (VHS)
PART I
Member States whose whole territory has disease-free status from VHS;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and
zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 ) Territory Denmark Whole territory Estonia Whole territory Ireland Whole territory Cyprus Whole continental territory Finland Whole territory Sweden Whole territory United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for VHS;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS;
and zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State Territory Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
Allegato XIIIANNEX XIII
INFECTIOUS HAEMATOPOIETIC NECROSIS (IHN)
PART I
Member States where their whole territory has disease-free status from IHN;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN;
and zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 ) Territory Estonia Whole territory Ireland Whole territory Cyprus Whole continental territory Finland Whole territory Sweden Whole territory United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for IHN;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and
zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State Territory Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
Allegato XIVANNEX XIV
INFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)
PART I
Member States where their whole territory has disease-free status from infection with HPR-deleted ISAV;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and
zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 ) Territory Belgium Whole territory Bulgaria Whole territory Czechia Whole territory Denmark Whole territory Germany Whole territory Estonia Whole territory Ireland Whole territory Greece Whole territory Spain Whole territory France Whole territory Croatia Whole territory Italy Whole territory Cyprus Whole territory Latvia Whole territory Lithuania Whole territory Luxembourg Whole territory Hungary Whole territory Malta Whole territory Netherlands Whole territory Austria Whole territory Poland Whole territory Portugal Whole territory Romania Whole territory Slovenia Whole territory Slovakia Whole territory Finland Whole territory Sweden Whole territory United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and
zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
Allegato XVANNEX XV
INFECTION WITH MARTEILIA REFRINGENS
PART I
Member States where their whole territory has disease-free status from infection with Marteilia refringens ;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and
zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 ) Territory Ireland Whole territory Sweden Whole territory United Kingdom (Northern Ireland) The whole coastline of Northern Ireland, except for Belfast Lough and Dundrum Bay. ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens ;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and
zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
Allegato XVIANNEX XVI
INFECTION WITH BONAMIA EXITIOSA
PART I
Member States where their whole territory has disease-free status from infection with Bonamia exitiosa ;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and
zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State Territory Estonia Whole territory Sweden Whole territory
PART II
Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa ;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
Allegato XVIIANNEX XVII
INFECTION WITH BONAMIA OSTREAE
PART I
Member States where their whole territory has disease-free status from infection with Bonamia ostreae ;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and
zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State ( *1 ) Territory Estonia Whole territory Ireland The whole coastline of Ireland, except: Cork Harbour; Galway Bay; Ballinakill Harbour; Clew Bay; Achill Sound; Loughmore, Blacksod Bay; Lough Foyle; Lough Swilly; Kilkieran Bay and Bertrabhoy Bay Sweden Whole territory except the coastal area from Altarefjorden in the north until Sälö fjord in the south. United Kingdom (Northern Ireland) The whole coastline of Northern Ireland, except: Lough Foyle and Strangford Lough. ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
PART II
Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae ;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
Allegato XVIIIANNEX XVIII
INFECTION WITH WHITE SPOT SYNDROME VIRUS (WSSV)
PART I
Member States where their whole territory has disease-free status from infection with WSSV;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and
zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
PART II
Member States where their whole territory has an approved eradication programme for infection with WSSV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and
zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
Allegato XIXANNEX XIX
INFESTATION WITH ECHINOCOCCUS MULTILOCULARIS
PART I
Member States or zones thereof with disease-free status from infestation with Echinococcus multilocularis in accordance with the conditions laid down in Annex V, Part V, Section 2, point (1), of Delegated Regulation (EU) 2020/689
Member State Territory Malta Whole territory
PART II
Member States or zones thereof with disease-free status from infestation with Echinococcus multilocularis , in accordance with the conditions laid down in Annex V, Part V, Section 2, point (2), of Delegated Regulation (EU) 2020/689
Member State ( *1 ) Territory Finland Whole territory Ireland Whole territory United Kingdom (Northern Ireland) Northern Ireland ( *1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community (OJ L 102, 17.4.2023, p. 87)) in conjunction with Annex 2 to that Framework, for the purposes of this Annex, references to Member States include the United Kingdom in respect of Northern Ireland.